Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
Clinical trial NCT01379508 · COMPLETED
Trial details
- NCT number
- NCT01379508
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-21
- Primary completion
- 2015-12-10
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.